BerandaCAMX • STO
add
Camurus AB
Tutup sebelumnya
kr 608,50
Rentang hari
kr 570,00 - kr 606,50
Rentang tahun
kr 415,80 - kr 715,00
Kapitalisasi pasar
35,79Â M SEK
Volume Rata-Rata
93,76Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (SEK) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 479,60Â jt | 24,90% |
Biaya operasional | 304,26Â jt | 22,71% |
Laba bersih | 129,35Â jt | 49,72% |
Margin laba bersih | 26,97 | 19,87% |
Penghasilan per saham | 2,16 | 44,00% |
EBITDA | 145,52Â jt | 35,34% |
Tarif pajak efektif | 21,75% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,75Â M | 138,44% |
Total aset | 3,57Â M | 93,65% |
Total liabilitas | 454,20Â jt | 28,54% |
Total ekuitas | 3,11 M | — |
Saham yang beredar | 58,81 jt | — |
Harga terhadap nilai buku | 11,50 | — |
Tingkat pengembalian aset | 10,13% | — |
Tingkat pengembalian modal | 11,66% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 129,35Â jt | 49,72% |
Kas dari operasi | 149,66Â jt | -69,19% |
Kas dari investasi | -5,93Â jt | -338,54% |
Kas dari pembiayaan | 42,49Â jt | 151,02% |
Perubahan kas bersih | 184,14Â jt | -63,16% |
Arus kas bebas | 62,81Â jt | -85,82% |
Tentang
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Didirikan
1991
Situs
Karyawan
225
